ARCH Venture Partners
Venture capital firm investing in early-stage science and technology companies.
Active
VC 🇺🇸 United States · United States ·
Since 1986
Deal flow
$674.3M
8 rounds
Unicorns
0
≥ $1B valuation
Founded
1986
40 yrs
Latest
Dec 2025
Paradigm Health
Venture capital firm investing in early-stage science and technology companies.
Aira
On-demand visual interpreting that makes the world accessible for blind and low-vision people
Paradigm Health
AI research platform making clinical trials part of routine patient care
Treeline Biosciences
Computational and experimental drug discovery for hard-to-drug cancer targets
Ollin Biosciences
Biotech advancing best-in-class bispecific antibody therapies for eye disease, using AI and